Results 51 to 60 of about 1,792,624 (390)
Misinformation of COVID-19 vaccines and vaccine hesitancy
Scientific Reports, 2022 The current study examined various types of misinformation related to the COVID-19 vaccines and their relationships to vaccine hesitancy and refusal.
Sun Kyong Lee +3 more
semanticscholar +1 more source
Challenges of Storage and Stability of mRNA-Based COVID-19 Vaccines
Vaccines, 2021 In December 2019, a new and highly pathogenic coronavirus emerged—coronavirus disease 2019 (COVID-19), a disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), quickly spread throughout the world.
M. Uddin, Monzurul A. Roni
semanticscholar +1 more source
COVID-19 vaccines: where we stand and challenges ahead
Cell Death and Differentiation, 2021 In the eleven months elapsed since the identification of the SARS-CoV-2 virus and its genome, an exceptional effort by the scientific community has led to the development of over 300 vaccine projects.
Guido Forni +26 more
semanticscholar +1 more source
COVID-19 vaccines: modes of immune activation and future challenges
Nature reviews. Immunology, 2021 The new vaccines against SARS-CoV-2 are novel in terms of specificity, their wide dissemination across the global population and the inclusion of newly licensed mRNA platforms.
J. Teijaro, D. Farber
semanticscholar +1 more source
Viral targets for vaccines against COVID-19
Nature reviews. Immunology, 2020 Vaccines are urgently needed to control the coronavirus disease 2019 (COVID-19) pandemic and to help the return to pre-pandemic normalcy. A great many vaccine candidates are being developed, several of which have completed late-stage clinical trials and ...
L. Dai, G. Gao
semanticscholar +1 more source
Mucosal vaccines — fortifying the frontiers
Nature reviews. Immunology, 2021 Mucosal vaccines offer the potential to trigger robust protective immune responses at the predominant sites of pathogen infection. In principle, the induction of adaptive immunity at mucosal sites, involving secretory antibody responses and tissue ...
E. Lavelle, Ross W. Ward
semanticscholar +1 more source
MMWR. Morbidity and mortality weekly report, 2021 Three COVID-19 vaccines are authorized or approved for use among adults in the United States (1,2). Two 2-dose mRNA vaccines, mRNA-1273 from Moderna and BNT162b2 from Pfizer-BioNTech, received Emergency Use Authorization (EUA) by the Food and Drug ...
W. Self +157 more
semanticscholar +1 more source
Midwives\u27 knowledge, attitudes and learning needs regarding antenatal vaccination [PDF]
, 2018 Objective: To determine the knowledge, attitudes and learning needs of midwives regarding antenatal vaccination. Design & Setting: A cross-sectional, paper-based survey of midwives employed at the only public tertiary maternity hospital in the Australian
Amirthalingam +32 more
core +2 more sources
Confidence and Receptivity for COVID-19 Vaccines: A Rapid Systematic Review
Vaccines, 2020 While COVID-19 continues raging worldwide, effective vaccines are highly anticipated. However, vaccine hesitancy is widespread. Survey results on uptake intentions vary and continue to change.
Cheryl Lin, Pikuei Tu, L. Beitsch
semanticscholar +1 more source
Immunogenicity and tolerability of an MF59-adjuvanted, egg-derived, A/H1N1 pandemic influenza vaccine in children 6-35 months of age [PDF]
, 2014 Background: Vaccines against pandemic A/H1N1 influenza should provide protective immunity in children, because they are at greater risk of disease than adults.
Abarca, Katia +9 more
core +2 more sources